Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study.
Details
Serval ID
serval:BIB_3CA002AEBD9B
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study.
Journal
Journal of Acquired Immune Deficiency Syndromes
ISSN
1944-7884[electronic], 1525-4135[linking]
Publication state
Published
Issued date
2010
Volume
55
Number
1
Pages
49-57
Language
english
Notes
Publication types: Comparative Study ; Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Keywords
Adenine/administration & dosage, Adenine/adverse effects, Adolescent, Adult, Aged, Anti-HIV Agents/administration & dosage, Anti-HIV Agents/adverse effects, Benzoxazines/administration & dosage, Benzoxazines/adverse effects, Deoxycytidine/administration & dosage, Deoxycytidine/adverse effects, Dideoxynucleosides/administration & dosage, Dideoxynucleosides/adverse effects, Drug Combinations, Female, Glomerular Filtration Rate/drug effects, HIV Infections/drug therapy, HIV-1/isolation & purification, Humans, Kidney/drug effects, Lamivudine/administration & dosage, Lamivudine/adverse effects, Male, Middle Aged, Phosphonic Acids/administration & dosage, Phosphonic Acids/adverse effects, Retinol-Binding Proteins/urine, Treatment Outcome, Viral Load, Young Adult, beta 2-Microglobulin/urine
Pubmed
Web of science
Create date
21/01/2011 14:28
Last modification date
20/08/2019 13:32
Usage data
